Filing Details

Accession Number:
0001213900-21-020918
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-04-08 21:47:32
Reporting Period:
2021-04-06
Accepted Time:
2021-04-08 21:47:32
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1513525 Adial Pharmaceuticals Inc. ADIL Pharmaceutical Preparations (2834) 800667150
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1718158 A. Bankole Johnson 1001 Research Park Blvd., Suite 100
Charlottesville VA 22911
Chief Medical Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2021-04-06 150,000 $2.50 548,336 No 4 S Indirect En Fideicomiso De Mi Vida 11/23/2010 (Trust)
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Indirect En Fideicomiso De Mi Vida 11/23/2010 (Trust)
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 1,055 Direct
Common Stock 40,463 Indirect Medico-Trans Company, LLC
Common Stock 93,000 Indirect En Fidecomiso de Todos Mis Suenos Grantor Retained Annuity Trust dated June 27, 2017
Common Stock 22,320 Indirect En Fideicomiso De Mis Suenos 11/23/2010 (Trust)
Common Stock 10,000 Indirect De Mi Amor 11/23/2010 (Trust)
Common Stock 4,650 Indirect Efunbowale Johnson
Common Stock 1,395 Indirect Ade Johnson
Common Stock 1,395 Indirect Lola Johnson
Common Stock 930 Indirect Lina Tiouririne
Common Stock 930 Indirect Aida Tiouririne
Footnotes
  1. The reporting person sold 150,000 shares of the issuer's common stock pursuant to a Stock Purchase Agreement dated as of April 6, 2021 for an aggregate purchase price of $375,000.
  2. Medico-Trans Company, LLC is controlled by Bankole Johnson.
  3. Dr. Johnson is the trustee of each of these trusts.
  4. Dr. Johnson has a voting proxy on this person's behalf that entitles him to vote these shares.